RENAISSANCE TECHNOLOGIES LLC

Position in RPRX — Royalty Pharma plc

CIK 1037389 NEW YORK, NY

Position in RPRX

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$108,540,306

+$70,599,059 QoQ

Shares Held

1,935,800

+144.7% QoQ

Ownership

0.337%

of shares outstanding

% of Portfolio

0.15%

of 13F equity value

Holder Rank

#38

of 646 holders

Holding Since

Jun 2021

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

RENAISSANCE TECHNOLOGIES LLC holds $3,950,489,724 across 311 Biotechnology names. RPRX ranks #6 (2.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	EXEL	Exelixis, Inc.	13,427,993	$730,617,099
2	CORT	Corcept Therapeutics Inc	5,261,628	$457,498,554
3	INCY	Incyte Corp	3,512,132	$398,135,283
4	VRTX	Vertex Pharmaceuticals Inc / Ma	320,008	$158,957,573
5	JAZZ	Jazz Pharmaceuticals plc	562,073	$135,442,730
6	RPRX	Royalty Pharma plc This page	1,935,800	$108,540,306
7	TVTX	Travere Therapeutics, Inc.	1,833,079	$104,137,217
8	GMAB	Genmab A/S	3,517,850	$96,635,339

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$108,540,306	1,935,800	+144.7%	Shares	Sole	2026-08-13
2026-03-31	$37,941,247	790,937	+7661.9%	Shares	Sole	2026-05-14
2024-03-31	$309,470	10,190	-97.9%	Shares	Sole	2024-05-13
2023-09-30	$13,114,048	483,200	-37.3%	Shares	Sole	2023-11-14
2023-06-30	$23,691,318	770,700	-40.8%	Shares	Sole	2023-08-11
2023-03-31	$46,871,427	1,300,900	+49.7%	Shares	Sole	2023-05-12
2022-12-31	$34,342,880	869,000	+372.5%	Shares	Sole	2023-02-13
2022-03-31	$7,164,744	183,900	-77.0%	Shares	Sole	2022-05-13
2021-12-31	$31,844,135	799,100	+2.0%	Shares	Sole	2022-02-11
2021-09-30	$28,319,304	783,600	-5.4%	Shares	Sole	2021-11-12
2021-06-30	$33,964,314	828,600	—	Shares	Sole	2021-08-13
No filing history on record for this holder in this stock.